Pharmerica Revenue, Profits - PMC Quarterly Income Statement

Add to My Stocks
$29.25 $0.05 (0.17%) PMC stock closing price Dec 07, 2017 (Closing)

Financial analysis of Pharmerica involves more than just checking the Pharmerica stock price, by looking at the financial statements of the company in detail. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. Like any other income statement, the PMC income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a QoQ revenue growth of 0.52% when compared to the same period in the past. One also needs to look at Pharmerica assets, operating expenses and Pharmerica free cash flow. The Pharmerica profit and loss statement shows revenue of $595.1M for 2017 Q3. Revenue has grown by 0.52% QoQ for PMC stock.

View and download details of revenue and profits for Pharmerica for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Pharmerica Revenues or Net Sales
595.1M592M566.8M534.4M512.6M519.6M524.5M520.6M
Cost Of Goods Sold (COGS)505.8M502.4M478.9M450.7M434.1M437.8M442.5M433.9M
Pharmerica Gross Profit
89.29M89.6M87.89M83.72M78.49M81.79M82M86.71M
Research & Development Expense--------
Selling General & Admin Expense69.1M68.1M69.6M63.7M58.2M66.1M65.9M58.7M
Income Before Depreciation Depletion Amortization20.19M21.5M18.29M20.02M20.29M15.69M16.1M28M
Depreciation Depletion Amortization10M9.9M9.1M9M8.3M8.2M8.2M8M
Non Operating Income--------
Interest Expense4.1M4.1M3.7M-3M3.3M3M1.2M
Pharmerica Pretax Income
6.1M7.5M5.5M10.8M9M4.2M4.9M18.8M
Provision for Income Taxes2.9M2.8M2M3.1M1.7M1.7M--1.4M
MinorityInterest--------
Investment Gains Losses--------
Other Income--------
Income Before Extraordinaries & Disc Operations3.2M4.7M3.5M7.7M7.3M2.5M4.1M20.2M
Extraordinary Items & Discontinued Operations--------
Pharmerica Profit/ Loss (Net Income)
3.2M4.7M3.5M7.7M7.3M2.5M4.1M20.2M
Average Shares used to compute Diluted EPS31.4M31.69M31.2M31.21M31.07M31.03M30.92M31.01M
Average Shares used to compute Basic EPS31.12M31.44M30.84M30.77M30.75M30.73M30.53M30.45M
Income Before Nonrecurring Items14.51M14.84M13.17M18M13.82M14.47M13.99M12.45M
Income from Nonrecurring Items-11.31M-10.14M-9.67M-10.3M-6.52M-11.97M-9.89M7.75M
Pharmerica Earnings Per Share Basic Net
0.100.150.110.250.240.080.130.66
Pharmerica Earnings Per Share Diluted Net
0.100.150.110.250.230.080.130.66
EPS Diluted Before Nonrecurring Items0.460.470.420.580.440.470.450.41
Preferred Dividends Acc Pd--------
Dividends Common--------
Dividend Per Share Common0.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Pharmerica stock analysis involves checking at least a few of the important things like:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that PMC stock has a topline or revenue of $595.1M for 2017 Q3 as per this Pharmerica revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $3.2M for Pharmerica for 2017 Q3. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The PMC financials along with Pharmerica historical stock prices provide a lot of details about the firm.

Pharmerica Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
47.95
PS Ratio (price sales ratio)
0.4
Operating Margin
2
Net Profit Margin
0.8
Dividend Yield
0%